Leishmaniasis patients could benefit from some of these reported positive effects, such as increased Th1 cell responses [179,180,181], increased production of IL-17 and IFN-γ by CD4+ T cells [180], and modulation of the immune response in intestinal epithelial cells and macrophages [183]. The gene discussed is IFNG; the disease is leishmaniasis.